Key Finding
Both electro-acupuncture and moxibustion reduced Crohn's disease activity and improved quality of life through distinct brain connectivity changes that negatively correlated with disease severity.
Researchers investigated how acupuncture and moxibustion affect brain function in patients with Crohn's disease, a chronic inflammatory bowel condition. The study involved 65 patients in remission who received either electro-acupuncture (32 patients) or moxibustion (33 patients) for 12 weeks. Brain scans were performed before and after treatment to observe changes in brain connectivity.
Both treatments proved beneficial, reducing disease activity scores and improving quality of life. However, the brain scans revealed that each treatment worked differently in the brain. Electro-acupuncture strengthened connections between the hippocampus (a brain region involved in memory and stress response) and areas that process bodily sensations, including the middle cingulate cortex and insula. Moxibustion, on the other hand, enhanced connections between the hippocampus and regions associated with the brain's default mode network, including the precuneus and inferior parietal lobe.
Interestingly, patients who showed greater improvements in disease activity also demonstrated stronger changes in these brain connections, suggesting the brain changes were related to clinical improvement. These findings help explain why both treatments can be effective for Crohn's disease while working through different neurological pathways.
What this means for patients: Both electro-acupuncture and moxibustion appear to be viable options for managing Crohn's disease during remission, with each therapy influencing different brain networks involved in processing inflammation and maintaining wellness. The choice between treatments might depend on individual patient response and practitioner expertise. If you're considering these therapies for Crohn's disease, consult with a licensed acupuncturist experienced in treating gastrointestinal conditions.
This randomized trial examined brain connectivity changes in 65 Crohn's disease patients in remission treated with either electro-acupuncture (n=32) or moxibustion (n=33) for 12 weeks. Resting-state fMRI was performed on 38 patients (18 electro-acupuncture, 20 moxibustion) pre- and post-treatment. Seed-based analysis assessed resting-state functional connectivity (rsFC) between bilateral hippocampus and other brain regions.
Both interventions significantly reduced CDAI scores and increased IBDQ scores. Electro-acupuncture enhanced rsFC between bilateral hippocampus and anterior middle cingulate cortex/insula (homeostatic afferent processing network), with changes negatively correlating with CDAI scores. Moxibustion increased rsFC between bilateral hippocampus and precuneus/inferior parietal lobe (default mode network), also negatively correlating with CDAI scores.
Clinical takeaway: Electro-acupuncture and moxibustion demonstrate therapeutic efficacy for CD through distinct neurological mechanisms—modulating homeostatic processing versus default mode networks, respectively. Both modalities merit consideration for managing CD in remission, with treatment selection potentially guided by individual patient neurofunctional profiles.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 A 12-week randomized controlled trial is underway to evaluate whether transcutaneous auricular vagus nerve stimulation (taVNS) can reduce body weight in patients with obesity by modulating the microbiota-gut-brain axis, assessed through fMRI, gut microbiota profiling, and serum brain-gut peptides.
📌 Acupuncture significantly reduced chronic urticaria activity scores and improved dermatology-related quality of life compared to sham acupuncture and waitlist control, performing comparably to Western medicine for symptom control.
📌 77.6% of women with moderate-to-severe menopausal symptoms experienced a clinically relevant reduction in symptoms following a standardized acupuncture protocol, with vocational education level being the most consistent predictor of treatment response.